Eric M. Green has been appointed chief executive officer of West Pharmaceutical Services, effective April 24, 2015. He succeeds Donald E. Morel, Jr., Ph.D., current chairman and chief executive officer, who plans to retire July 1, 2015. Dr. Morel will continue to serve as West’s Chairman.
 
Mr. Green joins the company from Sigma-Aldrich Corp., where he served as executive vice president and president of the company’s Research Markets business unit since 2013. Mr. Green served as a corporate officer and member of the senior executive team, with responsibility for managing the company’s largest business unit.
 
“Eric Green brings a wealth of leadership experience from his time with Sigma-Aldrich, a company which shares West’s customer-centric approach to working with the pharmaceutical industry,” said Dr. Morel. “Eric stood out among a very strong candidate list that was considered. We were particularly impressed with his track record of growing revenue and profit for the business units he has led; the diversity of his experience across different business segments, particularly in emerging markets; and his passion for leading people — all of which have prepared him well to lead West. I expect to be fully engaged in helping Eric acclimate to his new role at West and introducing him to our key stakeholders.”
 
“West is poised for an exciting future thanks to the work of the current management team under Don Morel’s leadership,” said Patrick J. Zenner, Chairman of the Independent Directors. “Eric Green shares the same vision we have for West and we are confident in his ability to lead the company to realize its potential for future growth in the coming years.”